Vitamin D deficiency is widespread in cancer patients and correlates with advanced stage disease: A community oncology experience

Nutrition and Cancer

Volumn 64, Issue 4, 2012, Pages 521-525

  Churilla, Thomas M ^a   Brereton, Harmar D ^a,b   Klem, Mary ^b   Peters, Christopher A ^a,b  

^a Janet Weis Children s Hospital   (United States)

^b Northeast Radiation Oncology Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; VITAMIN D;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CLINICAL EXAMINATION; CONTROLLED STUDY; CORRELATIONAL STUDY; DEMOGRAPHY; FEMALE; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; ONCOLOGY; PREDICTION; PROSPECTIVE STUDY; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; PENNSYLVANIA; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84861446615     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2012.661515     Document Type: Article

References (33)

1. Garland C and Garland F: Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 35, 217-220, 2006.
2. Giovannucci E: The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control 16, 83-95, 2005. (Pubitemid 40691207)
3. Holick M: Vitamin D deficiency. N Engl J Med 357, 266-281, 2007.
4. Schwartz G and Skinner H: Vitamin D status and cancer: new insights. Curr Opin Clin Nutr Metab Care 10, 6-11, 2007. (Pubitemid 44901127)
5. Gandini S, Boniol M, Haukka J, Byrnes C, Cox B, et al.: Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer 128, 1414-1424, 2011.
6. Grant WB: Effect of interval between serum draw and follow-up period on relative risk of cancer incidence with respect to 25-hydroxyvitamin D level: implications for meta-analyses and setting vitamin D guidelines. Dermatoendocrinol 3, 199-204, 2011.
7. Grant WB: Relation between prediagnostic serum 25-hydroxyvitamin D level and incidence of breast, colorectal, and other cancers. J Photochem Photobiol B 101, 130-136, 2010.
8. Grant W: Re: Prospective study of vitamin D and cancer mortality in the United States. J Natl Cancer Inst 100, 826, 2008. (Pubitemid 351809663)
9. Lappe J, Travers-Gustafson D, Davies K, Recker R, and Heaney R: Vitamin Dand calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 85, 1586-1591, 2007. (Pubitemid 46890428)
10. Polek T and Weigel N: Vitamin D and prostate cancer. J Androl 23, 9-17, 2002.
11. Pilz S, Tomaschitz A, Obermayer-Pietsch B, Dobnig H, and Pieber T: Epidemiology of vitamin D insufficiency and cancer mortality. Anticancer Res 29, 3699-3704, 2009.
12. Goodwin P, Ennis M, Pritchard K, Koo J, and Hood N: Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J Clin Oncol 27, 3757-3763, 2009.
13. Ng A, Kumar S, Rajkumar S, and Drake M: Impact of vitamin D deficiency on the clinical presentation and prognosis of patients with newly diagnosed multiple myeloma. Am J Hematol 84, 397-400, 2009.
14. Tretli S, Schwartz GG, Torjesen PA, and Robsahm TE: Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study. Cancer Causes Control 23, 363-370, 2011.
15. Drake MT, Maurer MJ, Link BK, Habermann TM, Ansell SM, et al.: Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma. J Clin Oncol 28, 4191-4198, 2010.
16. Fang F, Kasperzyk JL, Shui I, Hendrickson W, Hollis BW, et al.: Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer. PLoS One 6, e18625, 2011.
17. Robsahm TE, Tretli S, Dahlback A, andMoan J: Vitamin D3 from sunlight may improve the prognosis of breast-, colon-and prostate cancer (Norway). Cancer Causes Control 15, 149-158, 2004. (Pubitemid 38445361)
18. Shanafelt TD, Drake MT, Maurer MJ, Allmer C, Rabe KG, et al.: Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia. Blood 117, 1492-1498, 2011.
19. Kim HJ, Lee YM, Ko BS, Lee JW, Yu JH, et al.: Vitamin D deficiency is correlated with poor outcomes in patients with luminal-type breast cancer. Ann Surg Oncol 18, 1830-1836, 2011.
20. Thomas X, Chelghoum Y, Fanari N, and Cannas G: Serum 25-hydroxyvitamin D levels are associated with prognosis in hematological malignancies. Hematology 16, 278-283, 2011.
21. Holick M: Noncalcemic actions of 1,25-dihydroxyvitamin D3 and clinical applications. Bone 17, 107S-111S, 1995.
22. Adams J, Clemens T, Parrish J, and Holick M: Vitamin-D synthesis and metabolism after ultraviolet irradiation of normal and vitamin-D-deficient subjects. N Engl J Med 306, 722-725, 1982. (Pubitemid 12183624)
23. Holick M: Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79, 362-371, 2004. (Pubitemid 41115577)
24. Fleet JC, Desmet M, Johnson R, and Li Y: Vitamin D and cancer: a review of molecular mechanisms. Biochem J 441, 61-76, 2012.
25. Ingraham B, Bragdon B, and Nohe A: Molecular basis of the potential of vitamin D to prevent cancer. Curr Med Res Opin 24, 139-149, 2008. (Pubitemid 351160247)
26. Huotari A and Herzig K: Vitamin D and living in northern latitudes-an endemic risk area for vitamin D deficiency. Int J Circumpolar Health 67, 164-178, 2008.
27. Greene FL Page DL Fleming ID, Fritz AG, Balch CM, et al. (Eds.): AJCC Cancer Staging Manual, 6th ed. Springer Science and Business Media, New York, 2002.
28. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, et al.: Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96, 1911-1930, 2011.
29. Vashi PG, Trukova K, Lammersfeld CA, Braun DP, and Gupta D: Impact of oral vitamin D supplementation on serum 25-hydroxyvitamin D levels in oncology. Nutr J 9, 60, 2010.
30. Institute of Medicine: Dietary Reference Intakes for Calcium and Vitamin D. National Academies Press Washington DC, 2011.
31. Palmieri C, MacGregor T, Girgis S, and Vigushin D: Serum 25-hydroxyvitamin D levels in early and advanced breast cancer. J Clin Pathol 59, 1334-1336, 2006. (Pubitemid 46048345)
32. Rickles A Peppone L Huston A, Piazza K, and Skinner K: Serum 25-hydroxyvitamin D and prognostic tumor characteristics in breast cancer patient (abstract). American Society of Breast Surgeons, Washington, DC, 2011.
33. Grant W: A critical review of Vitamin D and cancer: a report of the IARC Working Group. Dermatoendocrinol 1, 25-33, 2009.